Skip to main content
. 2021 Nov 18;10(1):e105–e113. doi: 10.1016/S2214-109X(21)00461-7

Table 2.

Participant sociodemographic and pregnancy characteristics

All regimens (n=1051) Mifepristone and misoprostol (n=356) Misoprostol alone (n=593) Unknown (n=102)
Age, years 28·1 (6·0) 27·5 (6·3) 28·5 (5·8) 33·0 (12·7)
14 2 (<1%) 2 (1%) 0 0
15–19 50 (5%) 27 (8%) 17 (3%) 6 (6%)
20–24 271 (26%) 101 (28%) 136 (23%) 34 (33%)
25–29 340 (32%) 103 (29%) 214 (36%) 23 (23%)
30–34 211 (20%) 73 (21%) 116 (20%) 22 (22%)
35–39 137 (13%) 35 (10%) 89 (15%) 13 (13%)
40–44 36 (3%) 15 (4%) 18 (3%) 3 (3%)
45–49 3 (<1%) 0 2 (<1%) 1 (1%)
50 1 (<1%) 0 1 (<1%) 0
Level of education
No schooling 2 (<1%) 2 (1%) 0 0
Completed primary school 134 (13%) 97 (27%) 14 (2%) 23 (23%)
Completed secondary school 397 (38%) 117 (33%) 248 (42%) 32 (31%)
More than secondary school 518 (49%) 140 (39%) 331 (56%) 47 (46%)
Ascertainment of pregnancy
Took pregnancy test at home 700 (67%) 292 (82%) 334 (56%) 74 (73%)
Took blood test in a facility 285 (27%) 55 (15%) 205 (35%) 25 (25%)
Took urine test in a facility 114 (11%) 2 (1%) 105 (18%) 7 (7%)
Ultrasound 113 (11%) 89 (25%) 7 (1%) 17 (17%)
Late or missed period 37 (4%) 31 (9%) 1 (<1%) 5 (5%)
Pregnancy symptoms 13 (1%) 11 (3%) 0 2 (2%)
Other 1 (<1%) 0 0 1 (1%)
Duration of pregnancy 7·0 (2·2) 7·6 (2·6) 6·7 (1·8) 7·0 (1·4)
<7 weeks 518 (49%) 141 (40%) 330 (56%) 47 (46%)
7 to <9 weeks 340 (32%) 134 (38%) 174 (29%) 32 (31%)
9 to <12 weeks 141 (13%) 50 (14%) 75 (12%) 16 (16%)
12 to 22 weeks 52 (5%) 31 (9%) 14 (2%) 7 (7%)

Data are mean (SD) or n (%).